Literature DB >> 19756834

Fifteen-year experience of pediatric-onset mixed connective tissue disease.

Yi-Ying Tsai1, Yao-Hsu Yang, Hsin-Hui Yu, Li-Chieh Wang, Jyh-Hong Lee, Bor-Luen Chiang.   

Abstract

The aim of this study was to investigate the initial clinical manifestations, laboratory data, complications, and outcomes of patients with pediatric-onset mixed connective tissue disease (MCTD) in Taiwan. We reviewed medical charts of patients younger than 18 years with a diagnosis of mixed connective tissue disease based on the criteria of Kasukawa (1) at the pediatric department of National Taiwan University Hospital from 1993 to 2008. A total of 12 patients were included. All of the patients were female. The mean age at disease onset was 10.7 years (range 6.5 to 14 years). The most common symptoms at disease onset were polyarthritis (7/12 patients) and Raynaud's phenomenon (7/12 patients). The clinical symptoms changed with time, and other symptoms encompassing the criteria for MCTD developed sequentially. Inflammatory manifestations (arthritis, fever, and skin rash) improved following treatment, whereas sclerodermatous features (sclerodactyly, esophageal disease, and vasculopathy) persisted and were often unresponsive to therapy. The organ involvement-free rates at 2 years, 5 years, and 10 years were 91.7%, 78.6%, and 52.4%, respectively. In this retrospective study, sclerodermatous changes of internal organs were a poor prognostic factor in our population, and we emphasize that long-term follow-up is necessary, and appropriate treatment should be applied to improve the outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19756834     DOI: 10.1007/s10067-009-1276-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Stroke in an early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies.

Authors:  D D Dungan; M S Jay
Journal:  Pediatrics       Date:  1992-07       Impact factor: 7.124

Review 2.  Course of mixed connective tissue disease in children.

Authors:  H Michels
Journal:  Ann Med       Date:  1997-10       Impact factor: 4.709

3.  Mixed connective tissue disease associated with idiopathic portal hypertension and chronic thyroiditis.

Authors:  S Hirasaki; N Koide; H Ogawa; T Wada; A Sato; K Ujike; T Tsuji
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

4.  Mixed connective tissue disease in children and adolescents.

Authors:  W J Oetgen; J A Boice; O J Lawless
Journal:  Pediatrics       Date:  1981-03       Impact factor: 7.124

5.  Stroke and mixed connective tissue disease.

Authors:  W D Graf; J M Milstein; D D Sherry
Journal:  J Child Neurol       Date:  1993-07       Impact factor: 1.987

6.  A case of merged idiopathic portal hypertension in course of mixed connective tissue disease.

Authors:  Tsuyoshi Rai; Hiromasa Ohira; Etsuko Fukaya; Kazumichi Abe; Junko Yokokawa; Junko Takiguchi; Shoichiro Shishido; Yukio Sato
Journal:  Hepatol Res       Date:  2004-09       Impact factor: 4.288

7.  Clinical and laboratory findings in childhood mixed connective tissue disease: presence of antibody to ribonucleoprotein containing the small nuclear ribonucleic acid U1.

Authors:  J F Savouret; D S Chudwin; D W Wara; A J Ammann; M J Cowan; W L Miller
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

8.  Juvenile-onset mixed connective tissue disease: longitudinal follow-up.

Authors:  H A Tiddens; J J van der Net; E R de Graeff-Meeder; T J Fiselier; D J de Rooij; W H van Luijk; R Herzberger; L W van Suijlekom; W J van Venrooij; B J Zegers
Journal:  J Pediatr       Date:  1993-02       Impact factor: 4.406

9.  U1-70-kd autoantibody-positive mixed connective tissue disease in children. A longitudinal clinical and serologic analysis.

Authors:  R W Hoffman; J T Cassidy; Y Takeda; E I Smith-Jones; G S Wang; G C Sharp
Journal:  Arthritis Rheum       Date:  1993-11

10.  Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders.

Authors:  A Igarashi; K Nashiro; K Kikuchi; S Sato; H Ihn; M Fujimoto; G R Grotendorst; K Takehara
Journal:  J Invest Dermatol       Date:  1996-04       Impact factor: 8.551

View more
  7 in total

Review 1.  A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma.

Authors:  Liza J McCann; Clare E Pain
Journal:  Indian J Pediatr       Date:  2016-02       Impact factor: 1.967

Review 2.  Pediatric Mixed Connective Tissue Disease.

Authors:  Roberta A Berard; Ronald M Laxer
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

3.  Fatal Myocarditis in an Adolescent Girl with Evolving Connective Tissue Disease.

Authors:  Bipin Jose; Dantis Emmanuel; Preethy Harrison
Journal:  Indian J Pediatr       Date:  2019-05-10       Impact factor: 1.967

Review 4.  Rare Lung Diseases: Interstitial Lung Diseases and Lung Manifestations of Rheumatological Diseases.

Authors:  Mahesh Babu Ramamurthy; Daniel Y T Goh; Michael Teik Chung Lim
Journal:  Indian J Pediatr       Date:  2015-08-20       Impact factor: 1.967

5.  Capillaroscopy as a diagnostic tool in the diagnosis of mixed connective tissue disease (MCTD): a case report.

Authors:  Mislav Radić; Rebecca S Overbury
Journal:  BMC Rheumatol       Date:  2021-03-19

6.  Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children.

Authors:  Natalia Cabrera; Agnes Duquesne; Marine Desjonquères; Jean-Paul Larbre; Jean-Christophe Lega; Nicole Fabien; Alexandre Belot
Journal:  RMD Open       Date:  2016-09-15

7.  Mixed connective tissue disease in young Saudi patient with recurrent dental abscess: A case report.

Authors:  Asma'a Faden; Alaa Aljamili; Anfal Aljamili; Sumayyah Alahmari; Abdulrahman Asiri
Journal:  Int J Health Sci (Qassim)       Date:  2018 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.